Woo K T, Lau Y K, Yap H K, Lee G S, Chiang G S, Lim C H
Department of Renal Medicine, Singapore General Hospital, Republic of Singapore.
Nephron. 1989;52(4):300-6. doi: 10.1159/000185667.
Among 98 patients with IgA nephritis who had protein selectivity studies performed, 54% had nonselective proteinuria and the remaining 46% had selective proteinuria. Patients with nonselective proteinuria had a higher incidence of glomerulosclerosis. At the end of a 4-year follow-up period, patients with nonselective proteinuria had lower creatinine clearance, higher incidence of hypertension and chronic renal failure when compared to patients with selective proteinuria. Six out of eleven patients (55%) in the study who had the nephrotic syndrome had selective proteinuria. Among these 6 patients, 1 had spontaneous remission and 5 responded to steroid or cyclophosphamide therapy. The remaining 5 patients with nonselective proteinuria did not respond to therapy. In the patients who had selectivity studies repeated, the data showed that the selectivity index (SI) can fluctuate depending on the clinical course of the patients. SI can therefore be used to monitor the progress of patients on long-term follow-up. Protein selectivity appears to be a useful prognostic index in IgA nephritis. For patients with the nephrotic syndrome it may serve as a guide to therapy.
在98例进行了蛋白质选择性研究的IgA肾病患者中,54%有非选择性蛋白尿,其余46%有选择性蛋白尿。非选择性蛋白尿患者肾小球硬化的发生率更高。在4年随访期结束时,与选择性蛋白尿患者相比,非选择性蛋白尿患者的肌酐清除率更低,高血压和慢性肾衰竭的发生率更高。该研究中11例患有肾病综合征的患者中有6例(55%)有选择性蛋白尿。在这6例患者中,1例自发缓解,5例对类固醇或环磷酰胺治疗有反应。其余5例非选择性蛋白尿患者对治疗无反应。在重复进行选择性研究的患者中,数据显示选择性指数(SI)会根据患者的临床病程而波动。因此,SI可用于长期随访患者的病情监测。蛋白质选择性似乎是IgA肾病一个有用的预后指标。对于肾病综合征患者,它可作为治疗的指导。